Loading company…
Riskpilot
← Back to search
Sign in
Get full access
BAKKE CONSULTING AS
AS
Active
Org 982579961
Flanderborg 5, 7374 Røros
Business and other management consultancy activities · NACE 7020
Est. 2000
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 107K
-10% vs 2023
EBITDA margin
29.6%
-49% vs 2023
Equity ratio
97.9%
Financial strength
Net profit 2024
NOK 25K
-58% vs 2023
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2020
0M
0%
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 107K
-10%
EBITDA
NOK 32K
-49%
Net profit
NOK 25K
-58%
Total assets
NOK 2,1M
+2%
Equity
NOK 2M
+1%
Employees
1
—
Company information
Legal name
BAKKE CONSULTING AS
Org number
982579961
Legal form
Aksjeselskap
NACE code
7020 · Business and other management consultancy activities
Founded
6. november 2000
Share capital
NOK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Rådgivning og konsulentvirksomhet samt investeringsvirksomhet og hva dermed står i forbindelse.
Contact
Address
Flanderborg 5, 7374 Røros
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Business and other management consultancy activities
Companies in Røros
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
1M
2020
1M
2021
0M
2022
0M
2023
0M
2024
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
919
611
194
119
107
Staff expenses
−714
−598
−209
1
−0
EBITDA
35
−51
−65
62
32
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
35
−51
−65
62
32
Net financials
24
0
−0
14
0
Profit before tax
60
−51
−65
76
32
Tax
8
−11
−14
17
7
Net profit
52
−40
−51
60
25
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
2 230
2 098
1 976
2 017
2 052
Equity
2 015
1 975
1 925
1 984
2 009
Long-term debt
0
0
0
0
0
Short-term debt
215
122
51
33
43
Total debt
215
122
51
33
43
Financial ratios
5-year trend
EBITDA margin
29.6%
This company
15.8%
Market median
+87% vs market
2020
2024
Equity ratio
97.9%
This company
38.2%
Market median
+156% vs market
2020
2024
Return on equity
1.2%
This company
18.4%
Market median
-93% vs market
2020
2024
Net profit margin
23.2%
This company
8.1%
Market median
+186% vs market
2020
2024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
2020
2024
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
KH
Kjell Hans Bakke
Chairman
2000
SB
Sigrun Bakke
Board of Directors
2000
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Kristin Bakke Romsaas
Individual
15%
15%
2022
Hans Bakke
Individual
15%
15%
2022
Henning Bakke
Individual
15%
15%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
BAKKE CONSULTING AS
(this company)
ABIOSA PHARMA AS
Board network connections
Board members of BAKKE CONSULTING AS also hold positions in
0
other companies.
Person
Role here
Other companies
Kjell Hans Bakke
Chairman
0 companies
Sigrun Bakke
Board of Directors
0 companies